Form 8-K - Current report:
SEC Accession No. 0001193125-24-197008
Filing Date
2024-08-08
Accepted
2024-08-08 16:30:54
Documents
15
Period of Report
2024-08-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d875882d8k.htm   iXBRL 8-K 50282
2 EX-10.1 d875882dex101.htm EX-10.1 42969
3 EX-10.2 d875882dex102.htm EX-10.2 140005
  Complete submission text file 0001193125-24-197008.txt   407004

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA urgn-20240806.xsd EX-101.SCH 2846
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE urgn-20240806_lab.xml EX-101.LAB 17993
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE urgn-20240806_pre.xml EX-101.PRE 11258
17 EXTRACTED XBRL INSTANCE DOCUMENT d875882d8k_htm.xml XML 3643
Mailing Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007
Business Address 9 HA'TA'ASIYA ST RA'ANANA L3 4365007 972 9 770 7601
UroGen Pharma Ltd. (Filer) CIK: 0001668243 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38079 | Film No.: 241188971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)